212 related articles for article (PubMed ID: 28619026)
21. Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 Diabetes.
Natsuki Y; Morioka T; Kakutani Y; Yamazaki Y; Ochi A; Kurajoh M; Mori K; Imanishi Y; Shoji T; Inaba M; Emoto M
J Atheroscler Thromb; 2023 Dec; 30(12):1838-1848. PubMed ID: 37225519
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
[TBL] [Abstract][Full Text] [Related]
23. Relationship Between Total Serum Bilirubin Levels and Carotid and Femoral Atherosclerosis in Familial Dyslipidemia.
Amor AJ; Ortega E; Perea V; Cofán M; Sala-Vila A; Nuñez I; Gilabert R; Ros E
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2356-2363. PubMed ID: 29074587
[TBL] [Abstract][Full Text] [Related]
24. Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?
Kizilgul M; Kan S; Beysel S; Apaydin M; Ozcelik O; Caliskan M; Ozbek M; Ozdemir S; Cakal E
Arch Endocrinol Metab; 2017 Dec; 61(6):562-566. PubMed ID: 28977159
[TBL] [Abstract][Full Text] [Related]
25. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
[TBL] [Abstract][Full Text] [Related]
26. Correlation Analysis between Serum Vitamin D Levels and Lower Extremity Macrovascular Complications in Individuals with Type 2 Diabetes Mellitus.
Yang M; Liu J; Zhou X; Ding H; Xu J; Yang B; Sun B; Xiao D; Yu J; Gong Q
J Diabetes Res; 2019; 2019():4251829. PubMed ID: 31871946
[TBL] [Abstract][Full Text] [Related]
27. The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes.
Li MF; Zhao CC; Li TT; Tu YF; Lu JX; Zhang R; Chen MY; Bao YQ; Li LX; Jia WP
Cardiovasc Diabetol; 2016 Mar; 15():43. PubMed ID: 26944724
[TBL] [Abstract][Full Text] [Related]
28. Sortilin levels are associated with peripheral arterial disease in type 2 diabetic subjects.
Biscetti F; Bonadia N; Santini F; Angelini F; Nardella E; Pitocco D; Santoliquido A; Filipponi M; Landolfi R; Flex A
Cardiovasc Diabetol; 2019 Jan; 18(1):5. PubMed ID: 30634965
[TBL] [Abstract][Full Text] [Related]
29. Lower extremity arterial plaque in patients with type 2 diabetes mellitus: A cross-sectional study of 25-(OH)D
Hang X; Yu X; Fan S
J Diabetes Complications; 2024 Jan; 38(1):108665. PubMed ID: 38103536
[TBL] [Abstract][Full Text] [Related]
30. Serum fibroblast growth factor 23 levels do not correlate with carotid intima-media thickness in patients with chronic kidney disease.
Kaya B; Seyrek N; Paydas S; Karayaylali İ; Balal M; Aikimbaev K
Saudi J Kidney Dis Transpl; 2019; 30(5):1010-1021. PubMed ID: 31696838
[TBL] [Abstract][Full Text] [Related]
31. Circulating annexin A5 levels are associated with carotid intima-media thickness but not coronary plaque composition.
Burgmaier M; Reith S; Schurgers L; Kahles F; Marx N; Reutelingsperger C
Diab Vasc Dis Res; 2017 Sep; 14(5):415-422. PubMed ID: 28592134
[TBL] [Abstract][Full Text] [Related]
32. Angiopoietin-related growth factor is independently associated with lower extremity peripheral arterial disease.
Nie H; Liang Y; Wang HX; Ren HL; Wang YW; Li FD; Zheng YH
J Diabetes Complications; 2017 Feb; 31(2):433-438. PubMed ID: 27866700
[TBL] [Abstract][Full Text] [Related]
33. Association of serum proprotein convertase subtilisin/kexin type 9 with early atherosclerosis in newly diagnosed type 2 diabetes mellitus.
Guo W; Gong Y; Li J; Qin P; Lu J; Li X; Zhu W; Xu N; Zhou H; Zhang Q
Nutr Metab Cardiovasc Dis; 2019 Aug; 29(8):815-821. PubMed ID: 31133497
[TBL] [Abstract][Full Text] [Related]
34. Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: A retrospective study.
Chung YK; Lee YJ; Kim KW; Cho RK; Chung SM; Moon JS; Yoon JS; Won KC; Lee HW
Diab Vasc Dis Res; 2018 Jan; 15(1):24-30. PubMed ID: 29090609
[TBL] [Abstract][Full Text] [Related]
35. Circulating heat shock protein 27 as a novel marker of subclinical atherosclerosis in type 2 diabetes: a cross-sectional community-based study.
Wang X; Shi J; Lu B; Zhang W; Yang Y; Wen J; Hu R; Yang Z; Wang X
BMC Cardiovasc Disord; 2020 Apr; 20(1):198. PubMed ID: 32334520
[TBL] [Abstract][Full Text] [Related]
36. HbA1c is significantly associated with arterial stiffness but not with carotid atherosclerosis in a community-based population without type 2 diabetes: The Dong-gu study.
Lee YH; Shin MH; Choi JS; Rhee JA; Nam HS; Jeong SK; Park KS; Ryu SY; Choi SW; Kim BH; Oh GJ; Kweon SS
Atherosclerosis; 2016 Apr; 247():1-6. PubMed ID: 26854970
[TBL] [Abstract][Full Text] [Related]
37. Femoral Artery Atherosclerosis Is Associated With Physical Function Across the Spectrum of the Ankle-Brachial Index: The San Diego Population Study.
Wassel CL; Ellis AM; Suder NC; Barinas-Mitchell E; Rifkin DE; Forbang NI; Denenberg JO; Marasco AM; McQuaide BJ; Jenny NS; Allison MA; Ix JH; Criqui MH
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28729408
[TBL] [Abstract][Full Text] [Related]
38. Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease.
Imazu M; Takahama H; Asanuma H; Funada A; Sugano Y; Ohara T; Hasegawa T; Asakura M; Kanzaki H; Anzai T; Kitakaze M
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1504-11. PubMed ID: 25217649
[TBL] [Abstract][Full Text] [Related]
39. The estimated glomerular filtration rate is associated with subclinical atherosclerosis, independently of albuminuria, in patients with type 2 diabetes.
Lu B; Wan J; Yang Y; Li Y; Hu R
Int Angiol; 2013 Oct; 32(5):532-9. PubMed ID: 23903314
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. The CORDIOPREV study.
Rodríguez-Ortiz ME; Alcalá-Díaz JF; Canalejo A; Torres-Peña JD; Gómez-Delgado F; Muñoz-Castañeda JR; Delgado-Lista J; Rodríguez M; López-Miranda J; Almadén Y
Eur J Intern Med; 2020 Apr; 74():79-85. PubMed ID: 31899053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
